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Introduction: An effective immune response to severe bacterial infections requires a robust production of the
innate immunity cells from hematopoietic stem and progenitor cells (HSPCs) in a process called emergency
myelopoiesis. In sepsis, an altered immune response that leads to a failure of bacterial clearance is often observed. In
this study, we aimed to evaluate the impact of sepsis on human HSPCs in the bone marrow (BM) microenvironment
of humanized mice subjected to acute endotoxemia and polymicrobial sepsis.
Methods: Humanized mice (hu-NSG) were generated by transplanting NOD.Cg-Prkdc/scidIL2rγ (NSG) mice with the
human cord blood CD34+ cells. Eight weeks after the transplantation, hu-NSG mice were subjected to sepsis induced
by endotoxemia—Escherichia coli lipopolysaccharide (LPS)—or by cecal ligation and puncture (CLP). Twenty-four hours
later, HSPCs from BM were analyzed by flow cytometry and colony-forming unit (CFU) assay. CLP after inhibition of
Notch signaling was also performed. The effects of LPS on the in vitro proliferation of CD34+ cells from human BM
were tested by CellTrace Violet dye staining.
Results: The expression of Toll-like receptor 4 receptor was present among engrafted human HSPCs. Both CLP and
endotoxemia decreased (by 43 % and 37 %) cellularity of the BM. In addition, in both models, accumulation of early
CD34+ CD38− HSCs was observed, but the number of CD34+ CD38+ progenitors decreased. After CLP, there was a
1.5-fold increase of proliferating CD34+ CD38−Ki-67+ cells. Moreover, CFU assay revealed a depressed (by 75 %
after LPS and by 50 % after CLP) production of human hematopoietic colonies from the BM of septic mice. In
contrast, in vitro LPS stimulated differentiation of CD34+ CD38− HSCs but did not induce proliferation of these
cells in contrast to the CD34+ CD38+ progenitors. CLP sepsis modulated the BM microenvironment by upregulation
of Jagged-1 expression on non-hematopoietic cells, and the proliferation of HSCs was Notch-dependent.
Conclusions: CLP sepsis and endotoxemia induced a similar expansion and proliferation of early HSCs in the BM, while
committed progenitors decreased. It is suggestive that the Notch pathway contributed to this effect. Targeting early
hematopoiesis may be considered as a viable alternative in the existing arsenal of supportive therapies in sepsis.* Correspondence: tskirecki@gmail.com
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Despite the continuous progress in critical care medicine
and anti-microbial therapies, sepsis and septic shock re-
main a serious health-care problem worldwide. The
morbidity due to sepsis reaches 50–95 cases per 100,000
citizens in the USA annually [1], and the average mortal-
ity rates are high: 41 % in Europe and 28 % in the USA
[2]. It has been speculated in recent years that the com-
plex pathophysiology of sepsis coupled with the highly
heterogeneous makeup of patients with sepsis has hin-
dered successful development of specific anti-sepsis
drugs. Thus far, the major improvement in outcome has
been achieved by introduction of the Sepsis Surviving
Campaign Guidelines in 2004 [3].
The central role of immune system disturbances in
sepsis pathophysiology has been well recognized, and
an effort was made to comprehensively categorize those
disturbances. At the cellular level, fight against an
infection requires massive production of immune-
competent cells of the innate immunity. This process is
called emergency myelopoiesis and involves a robust
proliferation of hematopoietic progenitors and progres-
sion of dormant hematopoietic stem cells (HSCs) into
the cell cycle [4]. The emergency hematopoiesis repre-
sents a physiological response of the immune system to
infections that is governed by (a) direct stimulation of pro-
genitor cells via Toll-like receptors (TLRs) [5], (b) produc-
tion of growth factors and cytokines by the bone marrow
(BM) niche-forming cells and mature hematopoietic cells
(like granulocyte colony-stimulating factor, or G-CSF) [6],
and (c) paracrine effects of TLR-activated HSCs [7]. To
maintain hematopoietic homeostasis, a balance between
self-renewal and differentiation of ‘true’ HSCs must be
maintained. It was shown in the mouse that chronic in-
flammatory stimulation leads to an exhaustion of HSCs
in a model of multiple low-dose lipopolysaccharide
(LPS) injections [8]. Also, TLR stimulation was re-
ported to skew HSC differentiation toward myeloid
lineages [5]. Given that existing studies point out that
many patients with sepsis die with signs of compro-
mised immune defense and ongoing infections [9],
characterization of the emergency myelopoiesis dynamics
in sepsis is highly warranted. Although patients with sepsis
typically present with a robust blood leukocytosis, marked
leukopenia has been frequently reported in other subjects
with sepsis. In fact, both reactions are included in the
diagnostic criteria of sepsis [10]. It is currently not known
whether leukopenia is a consequence of the failure of HSC
response or an inadequate signaling in the BM micro-
environment. Yet, to date, no clinical studies have charac-
terized distribution of the BM stem and progenitor cells
and their potential modulation by sepsis syndromes. The
existing data on hematopoiesis under infectious condi-
tions come exclusively from experimental models ofinfections and sepsis in mice. Intriguingly, the data re-
garding HSCs and their progeny are conflicting.
Whereas the model of cecum ligation and puncture
(CLP) septic peritonitis led to an expansion of both
long-term HSCs (LT-HSCs) and short-term HSCs (ST-
HSCs) [11], Pseudomonas aeruginosa sepsis and LPS
endotoxemia expanded only the LT-HSCs. However,
LT-HSC functionality was compromised as shown in
the repopulating experiments [12]. Similarly, an intra-
venous injection of heat-killed Escherichia coli was
demonstrated to expand HSCs at the expense of mye-
loid progeny [13]. Although several mechanisms of the
HSC expansion in those conditions have been proposed
(e.g., proliferation of HSCs, block of differentiation, and
‘de-differentiation’ of committed progenitors), it re-
mains to be evaluated whether similar processes occur
in human sepsis.
The relevance of used mouse models of critical care
diseases has been recently vigorously discussed [14].
The recently developed humanized mice models that
rely on hu-HSC transplantation offer a high clinical
relevance to multiple investigative and mechanistic ap-
proaches in those mice [15]. For example, CLP sepsis
in humanized mice has already been shown to mimic
some of the features of immune disturbances observed
in patients with sepsis, including production of human
cytokines and apoptosis of human CD3 lymphocytes
[16]. After intravenous transplantation, hu-HSCs home
to murine BM in an SDF-1-CXCR4-dependent manner
[17] and recreate histological positioning within the
bone structure similar to the one present in humans
[18]. In regard to recapitulation of clinical sepsis syn-
dromes, several animal models have been developed
and used in the last decades. One of the most common
approaches is an injection of bacterial LPS. Although it
is currently not considered an appropriate simulation
of sepsis [19], it nevertheless constitutes a simple and
reproducible experimental system which evokes a
strong and transient release of inflammatory media-
tors. In contrast, CLP has been deemed much more
clinically relevant given that it reproduces many as-
pects of human septic peritonitis [19]. Although vari-
ous endpoints were previously compared in those two
models (i.e., LPS and CLP), a comparison of endotoxe-
mia and sepsis impact upon the hematopoietic stem
and progenitor cells (HSPCs) in the BM microenviron-
ment in a humanized mouse model system has been
never attempted.
In the present study, we aimed to investigate the
modulatory effects of CLP sepsis and LPS endotoxemia
on human HSPCs in the BM of the NOD.Cg-Prkdc/sci-
dIL2rγ (NSG) humanized mouse model. Specifically,
we set out (1) to characterize potential changes in the
phenotypes or markers (or both) of proliferation of the
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tion capacity of the grafted human hematopoietic pro-
genitor cells (HPCs).
Methods
Human umbilical cord blood CD34+ cells
Human umbilical cord blood (UCB) samples were proc-
essed in accordance with the procedures approved by
the Institutional Review Board of the Maria Sklodowska-
Curie Memorial Cancer Center and Institute of Oncology.
The UCB units from healthy donor mothers were ob-
tained with their informed consent. The UCB (30–50 ml)
was drained with the standard Baxter set with citrate vol-
ume reduced to 23 ml. Numbers of white blood cells and
mononuclear cells were estimated by using a Sysmex 820
semiautomatic hematological analyzer (Sysmex Co., Kobe,
Japan). Next, blood diluted 1:1 with phosphate-buffered
saline (PBS) was applied to Ficoll (Invitrogen Ltd, Paisley,
UK)-Uropoline (Polpharma SA, Starogard Gdanski,
Poland) of density of 1.077 g/ml and centrifuged for
40 min at 400 × g at 4 °C. Isolated cells were frozen in li-
quid nitrogen in Dulbecco’s modified Eagle’s medium
(Invitrogen Ltd) containing 50 % inactivated fetal bovine
serum (FBS) (Pan-Biotech GmbH, Aidenbach, Germany)
and 10 % dimethyl sulfoxide (DMSO) (Sigma-Aldrich, St.
Louis, MO, USA).
Enrichment of human HSCs was performed by isola-
tion of CD34+ cells from thawed UCB mononuclear
cells. CD34+ were separated by the positive immune sep-
aration method by using an EasySep CD34 kit (Stemcell
Technologies, Vancouver, BC, Canada) in accordance
with the protocol of the manufacturer. Purity of the iso-
lated cells was evaluated by flow cytometry after staining
with anti-CD45 FITC/anti-CD34 PE antibody cocktail
(BD Biosciences, San Jose, CA, USA). Each isolation
resulted in CD34+ cell purity of more than 90 %.
Mice and transplantation of CD34+ cells
NSG breeding pairs were obtained from The Jackson
Laboratory (Bar Harbor, ME, USA) and expanded and
maintained in the animal facility of the Center of Post-
graduate Medical Education (Warsaw, Poland). Mice
were kept under pathogen-free conditions and fed with
standard sterilized diet and sterile drinking water ad
libitum. The animal study was approved by Local Ethics
Committee No. 4 in Warsaw, Poland.
Four- to five-week-old female mice received intraperi-
toneal (i.p.) injection of busulfan (Sigma-Aldrich) for
two consecutive days before cell transplantation. Mice
were injected with the busulfan dose of 25 mg/kg in
100 μl of 30 % DMSO in saline. Twenty-four hours
after the last myeloablative injection, mice received
intravenous infusion (via a tail vein) of 105 purified
UCB CD34+ cells in 100 μl of 0.9 % NaCl. After thetransplantation, mice were observed and bred for further
experiments.
Model of LPS endotoxemia
Because of the variability in the level of human cell
chimerism after the transplantation of CD34+ cells, the
injected mice were pair-matched before the proper
experiments. Seven weeks after transplantation, 50 μl of
the peripheral blood was collected from the tail vein and
placed in the EDTA-containing tubes. Next, the total cell
count was evaluated (by using Bürker chamber and
Türk’s solution) and the percentage of human CD45+
cells was analyzed by flow cytometry after staining with
anti-CD45 PE antibody (BD Biosciences). Animals with
chimerism varying less that ±2 % were matched into
pairs and subjected to experimental endotoxemia or
CLP models. Eight weeks after the transplantation, the
selected paired mice were subjected to endotoxemia,
receiving an intravenous injection of 40 μg of LPS from
E. coli O55:B5 (Sigma-Aldrich) in 100 μl of 0.9 % saline
or 100 μl of saline as control.
Model of CLP sepsis
A CLP model of sepsis of moderate severity was also
performed 8 weeks after transplantation in accordance
with the original protocol developed by Chaudry’s lab
[20] with additional modifications [21]. In brief, mice
were anesthetized with i.p. injection of sodium pentobar-
bital (Sigma-Aldrich) with a dose of 30 mg/kg. A midline
incision was made, and after externalization, the cecum
was ligated (1 cm from the apex) and punctured twice
(through-through) with a 22-G needle. Next, a small
amount of fecal mass from the punctured cecum was
gently squeezed out to ensure patency of punctures,
cecum was relocated, and 4/0 sutures were used to close
the peritoneum and skin. Sham-operated mice under-
went only incision and cecum exteriorization.
Twenty-four hours after induction of endotoxemia or
CLP, mice were anesthetized with sodium pentobarbital
(200 mg/kg), bled from the retro-orbital plexus into
EDTA, and terminated. The BM from each femur was
flushed out with 0.5 ml of PBS. From some control mice,
splenocytes were isolated by mashing the spleen with a
needle. Blood and BM cells were counted by using Bürker
chamber and Türk’s solution.
Primary human bone marrow CD34+ cells in vitro
stimulation
Human BM was collected during the elective hip osteot-
omy from patients without severe comorbidities. Informed
consent was obtained from all patients, and the study was
approved by the local ethics board of the Center of Post-
graduate Medical Education (Warsaw, Poland). After red
blood cell lysis, CD34+ cells were isolated with an EasySep
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cells (4 × 105) were stained with CellTrace Violet dye (Life
Technologies, Carlsbad, CA, USA) in accordance with the
protocol of the manufacturer. Next, cells were resus-
pended in StemSpam medium (Stemcell Technologies)
with 10 % FBS, split, and cultured in 96-well plate with
1 μg/ml of LPS (E. coli O55:B5, Sigma-Aldrich) or control
medium. Cells were cultured in a humidified incubator
with low oxygen concentration: 1 % O2, 5 % CO2 and
94 % N2 for 9 days. To trace their proliferation history,
cells were stained after 9 days with anti-CD34 FITC, anti-
CD38 PE.Cy7, and 7-AAD (BD Biosciences) and analyzed
by flow cytometry.
Flow cytometry analysis
Immunophenotyping analysis of human cells was per-
formed by using a flow cytometry technique. Briefly,
70 μl of cell suspension was incubated for 5 min with
5 μl of inactivated mice serum to block murine Fc
receptors. Then, 5 μl of monoclonal antibodies—CD34-
APC, CD34 PE.Cy7, CD38-PE.Cy7, TLR4-PE, CXCR4-
biotin + streptavidin APC.Cy7, Lin-FITC (CD19, CD2,
CD3, CD14, CD66b, CD24, CD16, CD56, and CD235a),
CD45-AmCyan, CD19-PE, CD3-FITC, CD33-PerCP,
CD14-PE, CD235a-APC, and CXCR4-biotin (BD Bio-
sciences), TLR4-PE (R&D Systems, Minneapolis, MN,
USA), and G-CSFR-APC (BioLegend, San Diego, CA,
USA)—was added and incubated for 30 min at room
temperature. After staining, red blood cells were lysed
with BD Pharm Lyse solution (BD Biosciences) for
10 min, washed with PBS with 2 % Newborn Calf Serum
(NCS), and resuspended in 0.5 % paraformaldehyde in
PBS. For Ki-67 and Notch Intracellular Domain (NICD)
intracellular staining, fixed cells were washed with PBS and
permeabilized by 0.25 % Triton X-100 in PBS. Next, 5 μl of
anti-Ki-67 PE antibody, isotype control (BD Biosciences),
or anti-NICD (Cell Signaling Technology, Danvers, MA,
USA) was added for 30 min, and after PBS wash, cells were
resuspended again in paraformaldehyde. Prior to use, the
anti-NICD antibody was labeled by using a Zenon Alex-
Fluor 647 labeling kit (Life Technologies). For CXCR4
staining, before fixation, the cells were incubated with
Streptavidin-PE (BD Biosciences) for 30 min and washed.
Apoptosis of human HSPCs was analyzed with Annexin
V-PE (BD Biosciences) in accordance with the protocol of
the manufacturer. To analyze the expression of Jagged-1
on murine stromal cells, femurs of NSG mice were dis-
sected, crushed, and incubated in 0.1 % collagenase II in
PBS (Sigma-Aldrich) in 37 °C for 90 min. Then the cell
suspension was filtered via 70-μm mesh, washed in PBS,
and stained with anti-mouse antibodies: anti-Jagged-1 PE
antibody (eBioscience, San Diego, CA, USA), anti-CD31
and anti-rat IgG BV421 (BioLegend), and anti-CD45 FITC
(BD Biosciences). At least 400 (450–700) CD45−CD31+cells were collected in a flow cytometer. Phosphorylation
of STAT3 in human HSPCs was assessed by intracellular
staining with anti-pSTAT3-PE (pY705) antibody after
permabilization with Phosphoflow Perm Buffer II (all from
BD Biosciences) in accordance with the instructions of the
manufacturer. Samples were analyzed by using a FACS
Canto II cytometer (BD Biosciences) with Diva software.
Approximately 100,000 cells were collected for analysis.
Data analysis was performed with FlowJo software (Tree
Star, Inc., now part of FlowJo LLC, Ashland, OR, USA).
ModFit software was applied to analyze proliferation of
in vitro cultured BM CD34+ cells. All used anti-human
antibodies were tested for cross-reactivity with cells of
non-transplanted mice, and no staining was present.
In vivo inhibition of Notch signaling
To inhibit the Notch signaling pathway, mice were treated
with DAPT, a γ-secretase inhibitor. Two hours before
CLP surgery, hu-mice received i.p. injection of DAPT
(Sigma-Aldrich) (60 mg/kg) dissolved in 50 μl of DMSO.
The effects of Notch inhibition on human HSPCs were
evaluated 24 h after CLP.
Colony-forming unit assay
After erythrocyte lysis with Red Blood Cell Lysing Buffer
(Sigma-Aldrich), BM cells (5 × 105) from humanized mice
were used for the hematopoietic colony-forming unit
(CFU) assay. The human methylcellulose-based medium
(R&D Systems) contains 25 % FBS, 2 % bovine serum al-
bumin, 2 mM L-glutamine, and 5×10-5 M of mercap-
toethanol and is supplemented with rh-SCF (50 ng/ml),
rh-GM-CSF (10 ng/ml), rh-IL-3 (10 ng/ml), and rh-Epo
(3 IU/ml). Cells were plated in duplicate in 35-mm Petri
dishes. After 20 days of culture in a humidified incubator
in 37 °C and 5 % CO2, the colonies were counted under
an inverted microscope. CFU-GM (granulocyte macro-
phage), CFU-G (granulocyte), CFU-M (macrophage), and
CFU-E (erythroid)/burst-forming unit-erythroid (BFU-E)
colonies were identified. The medium was tested for
supporting growth of murine BM cells prior to experi-
ments, and no colonies were formed by cells from non-
transplanted mice.
Statistical analysis
Results are expressed as mean value ± standard devi-
ation. Absolute numbers of particular cell populations
were calculated from the total cell count and frequency
of given population. Statistical comparison between the
matched control and experimental animals was performed
with non-parametric Wilcoxon paired test. For multiple
comparisons, the one-way analysis-of-variance test with
Tukey’s post test was used after testing the normal dis-
tribution of data sets with Kolmogorov-Smirnov test. A
P value of less than 0.05 was considered significant.
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Prism 5 software (GraphPad Software, Inc., San Diego,
CA, USA) was used for all statistical analyses.Results
Development of the human multilineage reconstitution in
NSG mice
To enable a robust engraftment of human cells in the
NSG recipients, we performed a conditioning myeloabla-
tion with busulfan as reported by others [22]. The applied
regimen was well tolerated by all animals. Xenotrans-
plantation of 105 purified UCB CD34+ cells after 8 weeks
resulted in the BM engraftment by human cells at an aver-
age of 57.5 ± 22 %. This percentage is higher than reported
previously [22], but the increase can be attributed to the
modified regimen of the busulfan treatment (2 × 25 mg/
kg) that we used.Fig. 1 Development of human hematopoietic cells in the bone marrow of
Representative dot plots show flow cytometry analysis of bone marrow cel
mean frequency of human leukocyte subsets in the bone marrow of huma
mouse with anti-human CD45. c Morphology of bone marrow cells from h
in R1. e Analysis of monocytes. f Analysis of B cells. g Analysis of T cells. h Ana
cells (gated from R1). j Histogram comparing expression of TLR4 receptor on
on both undifferentiated Lineage− cells and mature Lineage+ cells. The values
gate. HSC hematopoietic stem cell, hu-NSG humanized NOD.Cg-Prkdc/scidIL2Among all human hematopoietic cells, we identified
HSPCs as well as differentiated myeloid and lymphoid
cells (Fig. 1). Although human erythrocytes were not
detected in the peripheral blood, the BM contained cells
from the erythroid lineage as determined by the expres-
sion of hu-glycophorin A (CD235a). In the peripheral
blood, the human CD45+ leukocytes were present at
frequencies of 1–29 %, mostly being CD19+ or CD33+
(data not shown). Within the splenocytes, hu-CD45+
cells were present at the average of 17 ± 9 %. Human
hematopoietic cells residing in the murine BM expressed
TLR4: the antigen was present on both differentiated
(Lineage+) and the Lineage− undifferentiated cells (Fig. 1j).
Both CD34+ CD38− HSCs and CD34+ CD38+ progenitors
(Fig. 1h) expressed TLR4; the TLR4 surface density was
higher on the latter cells (Fig. 1i).
In summary, a substantial difference in the frequency
of particular leukocyte populations in hu-NSG miceNSG mice 8 weeks after transplantation of human CD34+ cells.
ls with specific anti-human monoclonal antibodies. a Diagram showing
nized mice. b Staining of bone marrow from non-humanized NSG
u-NSG. d Expression of pan-hematopoietic CD45 antigen in cells gated
lysis of myeloid cells. i Analysis of hematopoietic stem and progenitor
HSCs and progenitor cells (gated from i). k Expression of TLR4 is present
on graphs present percentages of a given population from a maternal
rγ, NSG NOD.Cg-Prkdc/scidIL2rγ, TLR Toll-like receptor
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myeloid cells, together with expression of hu-TLR4
receptor, makes those mice a suitable model for study-
ing human-specific immune-inflammatory responses
elicited by sepsis and endotoxemia.
Endotoxemia and CLP modulated human hematopoietic
stem and progenitor cell populations in humanized mice
All animals survived the administered dose of LPS, and
the mortality in the CLP model reached 40 % after 24 h.
As specified in the Methods section, mice were matched
for experimental pairs on the basis of the frequency of
human chimerism in the peripheral blood of mice ana-
lyzed 7 days before experiments. The pairing was efficient
as the correlation coefficients (r) between groups were
0.899 (P = 0.016 in CLP experiments) and 0.677 (P = 0.022
in LPS experiments).
After 24 h, cellularity of the BM was markedly reduced
after both endotoxemia (3.7 × 106 ± 1.4 × 106/ml versusFig. 2 Analysis of human HSPC subpopulations in the murine bone marrow
human umbilical cord blood CD34+ cells, mice were subjected to endoto
surgery (CLP). Twenty-four hours later, bone marrow cells were harvested
analysis. Graphs in the upper panel (a, b, c, d) present results obtained in
impact of CLP on the human HSCPs. n = 6, *P < 0.05, **P < 0.01. C control, HSP
total cell count5.9 × 106 ± 2.7 × 106/ml, P < 0.05) and CLP (3.6 × 106 ±
1.6 × 106 versus 6.3 × 106 ± 3.7 × 106/ml, P > 0.05, Fig. 2a, e).
CLP-induced sepsis increased both the frequency (3.8 ±
1.1 % versus 0.65 ± 0.32 %, P < 0.01, Fig. 2f ) and total
cell count (1.5 × 105 ± 0.8 × 105/ml versus 0.3 × 105 ±
0.2 × 105/ml, P < 0.05, Fig. 2f ) of the early CD34+ CD38−
HSPCs. However, the frequency of the more committed
CD34+ CD38+ progenitors did not change significantly
after CLP. After LPS injection, the number of CD34+
CD38− cells was increased, but the difference did not
reach significance (13 ± 9.6 % versus 5.4 ± 2.9 %, P > 0.05,
Fig. 2b).
We also analyzed the proliferative status of the human
HSPCs by staining Ki-67, a protein indicative of cells that
are in the active phases of the cell cycle. The frequency of
Lin−CD34+ Ki-67+ HSPCs was significantly increased 24 h
after induction of CLP (2.08 ± 0.68 % versus 1.36 ± 0.69 %)
but not after endotoxemic challenge (Fig. 2d, h). Both
models induced expansion of early HSPCs in the BM, andafter induction of experimental sepsis. Eight weeks after transplantation of
xemia (40 μg of LPS intravenous) or cecal ligation and puncture
, counted, and stained with anti-human antibodies for flow cytometry
the model of endotoxemia, and graphs in the lower panel (e, f, g, h)
C hematopoietic stem and progenitor cell, LPS lipopolysaccharide, TCC
AB
Fig. 3 Analysis of the growth of human hematopoietic colonies
from bone marrow cells isolated from humanized mice 24 h after
induction of experimental sepsis. Twenty-four hours after induction
of experimental sepsis, bone marrow cells (5 × 105) from hu-NSG
were seeded on methylocellulose medium supplemented with
human growth factors. After 20 days of culture, the colonies formed by
human progenitor cells were counted. a Results from the model of
endotoxemia. b Results from the CLP-induced sepsis model. n = 6,
*P < 0.05, **P < 0.01. BMC bone marrow cell, CLP cecal ligation and
puncture surgery, hu-NSG humanized NOD.Cg-Prkdc/scidIL2rγ
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we assessed the more differentiated population of human
cells; CLP-induced sepsis led to a 3.5-fold reduction of
CD33+ myeloid cells (16.98 % versus 4.89 %, P < 0.05), but
the impact of sepsis on CD20+ B cells was insignificant.
Endotoxemia and CLP reduced hematopoietic colony
forming by human cells
In the next step, we aimed to test the impact of endotoxe-
mia and CLP on the functionality and number of hu-
hematopoietic progenitors. To do this, we used the CFU
assay with medium supplemented with recombinant hu-
man cytokines which do not support growth of murine
cells. The differences in baseline production of CFUs from
control mice in both models (Fig. 3) are a result of differ-
ent human chimerism after transplantation, but each time
control mice were paired with experimental mice on the
basis of human cell chimerism. Human hematopoietic
cells isolated from the BM of mice injected with LPS
formed four-fold fewer colonies compared with control
mice. A similar effect occurred in cells from CLP mice: a
two-fold reduction was observed.
Specifically, endotoxemia significantly reduced the
growth of CFU-G (2 ± 2 versus 26 ± 20) and CFU-M (0.85
± 0.5 versus 14.5 ± 9). In CLP mice, this phenomenon was
less dramatic in CFU-G (25.5 ± 17 versus 35 ± 14 in con-
trol, P < 0.05), but the number of CFU-M was not affected
(21.5 ± 15 versus 25.9 ± 13.9). In contrast, CLP reduced
the CFU-GM formation by 39 % (35 ± 23 versus 57 ± 23 in
control, P < 0.05), but endotoxemia did not influence that
type of progeny. Both models induced a markedly de-
creased the growth of BFU-E: in endotoxemia by 37-fold
and in CLP by three-fold (Fig. 3). In summary, both
models significantly diminished the functional activity of
human HPCs from the humanized BM.
Endotoxemia and CLP upregulated expression of TLR4
and CXCR4 on human HSPCs
Given that the HSPC fate can be influenced via TLR
receptors and that TLR4-mediated recognition of patho-
gens is considered a key signaling axis in Gram-negative
and polymicrobial infections, we then analyzed modula-
tion of the TLR4 expression. In CLP sepsis, there was a
two-fold increase in the frequency of the TLR4-positive
CD34+ CD38− cells (55 ± 13.4 % versus 26.1 ± 13.4 %;
Fig. 4a-d). Moreover, the geometric mean fluorescence
of anti-TLR4 staining increased by 43 % (Fig. 4b, d, g).
Similar results were obtained in endotoxemia: the TLR4-
positive CD34+ CD38− cells and the fluorescence inten-
sity increased by 63 % and 46 %, respectively (Fig. 4a, c).
Because the retention and mobilization of HSPCs can
contribute to changes in their BM quantity, we also
attempted to evaluate the impact of sepsis on the ex-
pression of CXCR4, the key receptor involved in themaintenance of HSCs in the BM. CLP increased the
density of CXCR4 on CD34+ CD38− cells (Fig. 4e, h),
whereas LPS had no effect on CXCR4 (Fig. 4f ).
LPS stimulated proliferation and differentiation of
primary human BM CD34+ cells in vitro
The modulation of hu-HSCs in in vivo models is the
sum of complex signaling stimuli triggered by sepsis.
Thus, we investigated how LPS-induced TLR4 stimula-
tion influences proliferation of purified HSPCs. After
9 days of culture, the presence of LPS reduced the fre-
quency of CD34+ CD38− HSCs by 44 % compared with
control (Fig. 5a). As the cells were stained with a fluores-





Fig. 4 (See legend on next page.)
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Fig. 4 Modulation of the expression of TLR4 and CXCR4 receptors on human HSCs. Changes of TLR4 (a, c) and CXCR4 (e) expression on
CD34+ CD38− cells 24 h after single LPS injection. Impact of CLP model on the modulation of TLR4 receptor expression (b, d) and CXCR4
expression (f). Representative histograms of TLR4 (g) and CXCR4 (h) expression on CD34+ CD38− HSCs from control and CLP mice are presented.
n = 6, *P < 0.05, **P < 0.01. CLP cecum ligation and puncture, GMF geometric mean fluorescence, HSC hematopoietic stem cell, LPS
lipopolysaccharide, TLR Toll-like receptor
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medium alone, CD34+ CD38+ cells displayed higher pro-
liferative activity (defined by proliferative index [23]) in
comparison with CD34+ CD38− cells (14.3 ± 5.4 versus
7 ± 2.1, P < 0.05) (Fig. 5b). The addition of LPS did not
influence the proliferative index of CD34+ CD38− HSCs,
but the index strongly increased in CD34+ CD38+ cells
(P < 0.001) (Fig. 5c). We also calculated frequency of theA
C
E
Fig. 5 Impact of LPS on the differentiation and proliferation of purified CD
CD34+ CD38− subpopulation after 9 days of culture. b Effect of LPS on the
CD34+ CD38+ cells in the presence of LPS. Impact of LPS on the frequency of
and third generations of daughter cells (fewer than four generations). All resu
*P < 0.05, **P < 0.001. BM bone marrow, LPS lipopolysaccharidedaughter cells in the first, second, and third generations.
LPS did not change the frequency of CD34+ CD38− cells
within the sum of fewer than four generations, but it sig-
nificantly decreased frequency of the CD34+ CD38+ cells
in fewer than four generations (by nine-fold) (Fig. 5d, e).
These observations suggest that LPS accelerated the
proliferation of the more differentiated CD34+ CD38+
cell population.B
D
34+ human BM cells in vitro. a Effect of LPS on the frequency of the
proliferative index of CD34+ CD38+ subpopulation. c Proliferation of
CD34+ CD38− cells (d) and CD34+ CD38+ cells (e) within first, second,
lts obtained after 9 days of culture in atmosphere of 1 % O2. n = 6,
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bone marrow
The Notch signaling pathway is co-responsible for main-
taining the quiescent HSCs. Therefore, in the last step,
we evaluated the expression of Notch-1 ligand Jagged-1
in the murine marrow stromal cells. Twelve hours after
the LPS injection, the expression of Jagged-1 was upreg-
ulated on the CD45− fraction and CD45−CD31+ endo-
thelial cells by 35 % (P < 0.05) (Fig. 6).
Sepsis activated the Notch signaling pathway that was
responsible for the expansion of human HSCs
To assess the contribution of Notch signaling pathway
in the expansion of human HSCs during CLP sepsis, we
treated hu-mice with DAPT prior to the CLP surgery.
DAPT is a γ-secretase inhibitor known to efficiently
block the cleavage of the NICD which subsequently acti-
vates transcription of downstream target genes [24]. The
activation of Notch-1 signaling was detected by staining
of its cytoplasmic subunit, NICD.
CLP led to a significant increase in the fluorescence of
NICD in CD34+ CD38− cells which was abrogated by
DAPT pretreatment (Fig. 7a). This effect was similar in
CD34+ CD38+ cells, although the differences did not
reach significance (Fig. 7a). The Notch blockade resulted
in a seven-fold reduction of the expansion of primitive
CD34+ CD38− (Fig. 7b, c) but had no effect on the moreA
Fig. 6 Endotoxemia modulates expression of Jagged-1, a Notch-1 ligand o
LPS (40 μg), murine femurs were crushed and digested with collagenase II,
and anti-mouse Jagged-1 antibodies. Expression of Jagged-1 on murine CD45
overlay of the expression of Jagged-1 after LPS injection and in control m
fluorescence, LPS lipopolysaccharidemature CD34+ CD38+ population (Fig. 7d, e). In addition,
the percentage of actively proliferating CD34+ Lin− HSCs
decreased in the presence of DAPT from 58 % to 37 %
(P < 0.001, Fig. 7f ).
To analyze the mechanisms controlling the HSC num-
ber, the rate of apoptosis was also measured. CLP alone
increased the rate of Annexin V-positive CD34+ CD38−
HSCs by five-fold (P > 0.05), and DAPT treatment fur-
ther augmented this rate by 15-fold compared with sham
animals (P < 0.001, Fig. 7g).
As the response to bacterial infections often evokes the
G-CSF-driven process of emergency myelopoiesis [4], we
analyzed the impact of sepsis on the expression of G-CSF
receptors on human HSPCs. CLP increased the expression
of G-CSFR on the surface of CD34+ CD38− cells (P < 0.05)
and CD34+ CD38+ cells (P > 0.05) and this effect was inde-
pendent of the Notch activity (Fig. 7h).
The G-CSFR-induced stimulation of HPCs during
emergency hematopoiesis is mediated by phosphoryl-
ation of STAT3 protein which activates translation of
downstream genes [4]. Sepsis increased the percentages
of both CD34+ CD38− and CD34+ CD38+ with phos-
phorylated STAT3 and this effect was diminished by
DAPT treatment, suggesting partial crosstalk between
these two pathways (Fig. 7i). These results imply broad
effects of Notch signaling in the proliferation and sur-
vival of HSCs during sepsis.B
n the bone marrow endothelial cells. Twelve hours after injection of
and then cells were stained with anti-mouse CD45, anti-mouse CD31,
−CD31+ endothelial cells was measured (a). b Representative histograms























































































































Fig. 7 Effects of Notch pathway inhibition in human HSPCs 24 h after induction of CLP sepsis in hu-mice. Pretreatment with DAPT (60 mg/kg)
2 h before CLP surgery inhibited activation of Notch-1 assessed by fluorescence intensity of NICD (a). Impact of the inhibition of Notch signaling
on the CLP-induced expansion of CD34+ CD38− HSCs (b, c) and effect on CD34+ CD38+ progenitors (d, e). Influence of DAPT treatment on the
frequency of proliferating HSCs (f), and the rate of apoptosis of CD34+ CD38− cells (g). Effect of DAPT on the expression of G-CSFR on HSPCs after
CLP (h), and the phosphorylation of STAT3 (i). n = 3–5. *P < 0.05, **P < 0.001, ***P < 0.001. CLP cecum ligation and puncture, G-CSFR granulocyte
colony-stimulating factor receptor, GMF geometric mean fluorescence, HSC hematopoietic stem cell, HSPC hematopoietic stem and progenitor
cell, NICD Notch-1 intracellular domain
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This is the first study in which humanized mice were
employed to study human HSPCs in the BM niche
during experimental sepsis and endotoxemia. Both
challenges in the chimeric mice provoked an active
expansion of the primitive HSC populations with a
concomitant decrease of the more committed progeni-
tor pool. Moreover, we show that the changes observed
in humanized mice were in contrast to those recorded
after in vitro stimulation of HSPCs with LPS. Those
findings underscore the importance of complexity of
signal interactions in the BM and advance knowledge
on the immune system reprogramming occurring dur-
ing severe sepsis.
Similarly to other studies, the main population of the
hu-BM cells consisted of B cells [25], whereas T cells
constituted only 3 % of the total BM cells. The recapitu-
lation of human sepsis T-cell response in hu-mice has
already been reported by the Hotchkiss group [16]. Intheir study, the CLP sepsis induced apoptosis of T cells
and reduced the delayed-type hypersensitivity response
[16]. Also, the myeloid cells in hu-mice were reported to
display functional responses to cytokine stimulation
(phosphorylation of STAT3 and STAT5 in response to
G-CSF and STAT1, STAT3, and STAT5 after interferon-
gamma treatment) [26].
Given that our mice developed a substantial percent-
age of CD33+ cells, they appear adequately competent to
recapitulate such a response to sepsis. Human cells in
the BM of our hu-mice express the TLR4 receptor, the
major pattern-recognition receptor for LPS. TLR4 recep-
tor was present on both differentiated cells (Lineage+)
and HSPCs (Fig. 1h, i). Interestingly, 8 weeks after trans-
plantation, hu-CD34+ cells constituted up to 13 % of
human BM cells, and the CD34+ CD38− subpopulation
was up to 5 %. These values are significantly higher than
in the human BM, where those cell populations consti-
tute, on average, 1.4 % and 0.1 %, respectively [27]. This
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for self-renewal of the hu-HSPCs or their differentiation
impairment in the murine BM niche. Altogether, our
current model is suitable to study the impact of sepsis
on human HSPCs.
To provide a wide coverage to the studied aim, we
employed two different models, namely non-microbial
endotoxemia and polymicrobial CLP. Because they differ
in the kinetics of cytokine response [28] and in several
other discrepancies existing between those two models
[29], this enabled us to investigate potential differences
in HSPC responses in two highly inflammatory milieus
of different origin.
The uniform reduction in the BM cellularity after endo-
toxemia and sepsis can be explained by mobilization of
myeloid cells to the peripheral blood and spleen [30].
However, the same number of BM cells from septic ani-
mals gave a lower number of hematopoietic colonies. This
was observed in all types of colonies and in both models
yet with a stronger suppression of CFU-M and CFU-G in
endotoxemia. Interpretation of our findings is difficult as
no similar studies have been performed in humanized
mice to date; we can only compare our results with those
obtained in immunocompetent (non-humanized) mice.
Rodriguez et al. reported a similar inhibition of myeloid
colony formation after injection of LPS from P. aeruginosa
in C57/BL6 mice [12]. Also, a decrease of the erythroid
colony formation was shown after induction of peritoneal
sepsis in vivo as well as in vitro LPS stimulation of the BM
cells [31]. In contrast, in different pre-clinical models,
sepsis exerted a stimulatory effect on myeloid colonies
[31, 32]. The discrepancy of the myeloid progenitor activ-
ity between the abovementioned studies may be attributed
to differences between the models themselves or their se-
verity or both. In the future, it would be of interest to
compare dynamic changes in the HSPC compartment of
humanized mice subjected to sepsis of different severity.
Both endotoxemia and sepsis increased the frequency
and the total cell count of CD34+ CD38− cells in the BM
of hu-NSG. Especially, the increase of the total number
of those cells indicates that their expansion progressed
in an active manner. Support for this claim comes from
the upregulation in the expression of the Ki-67 protein
that is expressed in cycling cells [33]. Although CLP had
a much stronger effect on the expression of Ki-67 in
HSPCs, endotoxemia also increased frequency of prolif-
erating cells. More differentiated CD34+ CD38+ cells
were not significantly affected in our models, but a ten-
dency to their reduction could be seen after LPS injec-
tion. CLP also reduced the pool of BM human CD33+
myeloid cells similarly to wild-type models [30]. As it
was shown that the mobilization of granulocytes from
BM ‘paves the way’ for egress of progenitor cells [34],
this mechanism can contribute to the decrease of theBM progenitor pool in our model. Our results are con-
sistent with data from a different type of endotoxemic
insult: an infusion of P. aeruginosa LPS increased early
HSCs but inhibited the colony formation [12].
The role of TLR4 signaling in HSPCs during infections
has been controversial. On one hand, the expansion of
HSCs from TLR4−/− mice to LPS was absent [11, 12]; on
the other hand, those mice showed unchanged response
to CLP and peritonitis [11, 35]. Nevertheless, recent re-
ports prove the importance of TLR4 signaling in the
steady-state granulopoiesis [36]. Interestingly, in our
models, the expression of TLR4 was upregulated on
both CD34+ CD38− and CD34+ CD38+ cells and this is
in contrast to modulation of those receptors on mono-
cytes from patients with sepsis [37]. This collectively
suggests an active participation of TLR4 in the response
of HSPCs to sepsis. Moreover, in the CLP sepsis model,
expression of CXCR4 on HSPCs was increased. A simi-
lar LPS-induced upregulation was observed in neutro-
phils, B cells, and murine HSPCs [38–40]. Such a
receptor modulation may be responsible for enhanced
retention of HSPCs in the BM or peripheral tissues [41].
To unravel the role of the BM microenvironment in
the sepsis-induced HSC expansion, we traced the prolif-
eration history of purified hu-CD34+ BM cells after
culturing them in vitro with LPS. The results of the LPS
experiment are in a stark contrast to the results obtained
in hu-mice: LPS decreased the pool of CD34+ CD38−
cells and strongly stimulated divisions of differentiated
CD34+ CD38+ cells. We interpret this in vitro-versus-
in vivo discrepancy as proof for a strong influence of the
BM microenvironment. To date, several important com-
ponents of the BM niche have been recognized. As we
maintained the cell culture in a hypoxic atmosphere that
resembles conditions of the BM niche [42], we doubt
that this factor had influenced the observed differences.
Although we stimulated purified CD34+ cells with puri-
fied LPS, it was shown that CD34+ HSPCs are potent
producers of cytokines and growth factors [43] and that
the TLR4 signaling even increases production of cyto-
kines by HSPCs (verified for murine cells [7]). Thus,
cytokines produced in such an autocrine manner were
likely present in our 9-day culture similarly to the BM
milieu.
Altogether, we hypothesize that reshaping of the
intercellular signaling in the BM niche may be respon-
sible for the expansion and blocking of HSC differenti-
ation in hu-mice. To identify a potential candidate
responsible for this phenomenon, we evaluated the
Jagged-1 (a ligand for Notch-1 receptor) expression
after endotoxemia. Notch-1 signaling is a well-known,
evolutionally conserved pathway that stimulates expan-
sion and inhibits differentiation of early HSCs [44]. In-
deed, LPS upregulated Jagged-1 expression on marrow
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CLP sepsis activated Notch-1 signaling in HSPCs, dem-
onstrating that this pathway was responsible for the
sepsis-induced proliferation and expansion of HSCs.
Furthermore, this proliferation was dependent, at least
partially, on the activation of STAT3. Concomitant up-
regulation of G-CSFR on HSCs during sepsis, a known
inducer of STAT3 phosphorylation during emergency
myelopoiesis, is probably responsible for the majority
of STAT3 activation [45]. The crosstalk between Notch
and STAT3 pathways was reported before [46], and our
results suggest that such an interaction may be import-
ant during severe infections in HSCs. Interestingly, sep-
sis itself induced apoptosis (annexin V binding) in
HSCs and to a greater extent in HPCs. Inhibition of
Notch signaling by DAPT further increased the rate of
apoptosis of HSCs but not HPCs. This finding under-
lines the exclusive importance of the Notch pathway in
maintaining the expansion of more primitive HSCs.
Therefore, it may be hypothesized that the activation of
Notch in HSCs during sepsis serves as a mechanism
that protects those cells from exhaustion during
massive infections but may also reduce their matur-
ation into more differentiated progenitors.
Our study has several drawbacks. Although hu-mice
develop human immunocompetent cells, their compos-
ition does not ideally reflect the physiological human
immune system. Moreover, the human cells are not fully
differentiated. Thus, particular defense and regulatory
mechanisms may be partially impaired or deregulated or
both. Another limitation is the partial cross-reactivity of
murine cytokines with human cells (e.g., M-CSF and
interleukin-15 [47]).
Conclusions
In summary, we report that both endotoxemia and CLP
induced proliferation and accumulation of human HSPCs
in the BM niches but that the pool of hematopoietic pro-
genitors strongly decreased. As this phenomenon was not
recapitulated in the in vitro LPS stimulation of purified
HSPCs, it highlights the importance of the BM micro-
environment in modulation of HSPCs during sepsis.
Furthermore, our findings suggest that increased Notch-1
signaling via Jagged-1 contributed to the abovementioned
modulation. It is suggested that the impairment of HSC
maturation in endotoxemia and sepsis may have signifi-
cant implications in the development and progress of
various immune disturbances in affected patients.
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